首页> 外文期刊>Case Reports in Pulmonology >Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
【24h】

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol

机译:患者在患有肺动脉高血压的患者中用ε

获取原文
       

摘要

A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup.
机译:一个35岁的女性患有肺动脉高压(PAH),患有逐渐恶化的吞咽困难,面部肿胀和呼吸急促,发现有一个大的哥工人。在长时间用贝丙醇烯醇治疗的患者中,甲状腺疾病是常见的。大多数甲状腺疾病病例描述了甲状腺毒症和甲状腺素静脉鼠标,但我们的情况是长期IV ePoprostenol的患者呈现出具有优越的腔静脉综合征(SVC),如外观和气道妥协,发现在处理过程中偶然有甲状腺肿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号